Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients

<div>Kaplan-Meier analysis of overall survival (OS). (a) OS according to the proportion of glomeruloid microvascular proliferation (MP, low-medium versus high). (b) OS according to the number of all visible blood vessels (Vsl, &lt;median versus ≥median). (c) OS according to the vascular staining intensity of CD133 (CD133si, &lt;median versus ≥median). (d) OS according to the vascular staining intensity of ICAM-1 (ICAMsi, &lt;median versus ≥median).</div>

Neuroscience Journal

fig2

Figure 2

Figure 2: Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients 